Cancer patients want honesty, compassion from their oncologist

November 04, 2009

What do patients want from their radiation oncologists? The most significant preference is that more than one-third of female cancer patients (37 percent) prefer to have their hands held by their radiation oncologists during important office visits, compared to 12 percent of men, according to a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Another significant finding is that almost three-quarters of the patients (72 percent) preferred to be called by their first name, even among elderly patients. There is a greater preference for this among females than males (76 percent to 66 percent), and white patients compared to blacks (74 percent to 56 percent). The study also shows that while 95 percent of all patients want their oncologist to be honest with them about their chances of cure and expected survival, there is a significantly increased preference for honesty among prostate cancer patients versus lung cancer patients (97 to 91 percent).

"In oncology, a strong physician-patient relationship is essential because the patient's interactions with their doctor can help the patient confidently make life or death decisions, such as what cancer treatment is best for them," Ajay Bhatnagar, M.D., lead author of the study, a radiation oncologist at Cancer Treatment Services International in Casa Grande, Ariz., and Adjunct Assistant Professor of Radiation Oncology at the University of Pittsburgh Cancer Institute in Pittsburgh said. "Oncologists can use these results to provide greater patient satisfaction for their patients, and therefore significantly improve patient care."

The study sought to find out what cancer patients wanted from their patient-doctor relationship and whether their physicians would be able to change their behaviors to satisfy their patients' preferences if they had knowledge of these preferences. The prospective randomized trial took place between June 2006 and March 2008 and involved 508 patients, who underwent radiation for breast, prostate or lung cancer. Patients answered a survey about their preferences of their radiation oncologist, with a variety of questions focusing on the patient-doctor relationship. The survey was given at three time periods: prior to initial consultation, midpoint of radiation treatment, and at completion of radiation therapy.

The patients were randomized into two groups, based on whether their oncologist reviewed their initial patient preference survey responses (experimental group) or did not (control group). At time of completion, the patient also completed a satisfaction survey.

In addition to other findings, nearly three-quarters of all patients (70 percent) are neutral about their radiation oncologist wearing a white coat or professional clothing. The study also shows that 95 percent of high school graduates show a greater preference for having their radiation treatment described in everyday language by their radiation oncologists, compared to 91 percent of college graduates and 84 percent of post-graduate patients.
-end-
For more information on radiation for cancer, visit www.rtanswers.org.

The abstract, "What Do Patients Want From Their Radiation Oncologist? Final Results From A Prospective Randomized Trial," will be presented at a scientific session at 11:00 a.m. on Wednesday, November 4, 2009. To speak to the lead author of the study, Ajay Bhatnagar, M.D., please call Beth Bukata or Nicole Napoli November 1-4, 2009, in the ASTRO Press Room at McCormick Place West at 312-791-7005 or 312-791-7006. You may also e-mail them at bethb@astro.org or nicolen@astro.org.

American Society for Radiation Oncology

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.